α7 Nicotinic receptor agonist-1

Modify Date: 2024-04-05 14:44:59

α7 Nicotinic receptor agonist-1 structure	Common Name	α7 Nicotinic receptor agonist-1
	CAS Number	220100-05-0	Molecular Weight	231.29
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₃H₁₇N₃O	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of α7 Nicotinic receptor agonist-1

α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer's disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder)[1].

Name	α7 Nicotinic receptor agonist-1

Description	α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer's disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder)[1].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> nAChR Signaling Pathways >> Neuronal Signaling >> nAChR Research Areas >> Neurological Disease
Target	α7 nAChR[1].
References	[1]. James Loch Iii, et al. Novel aralkyl amines of spirofuropyridines useful in therapy. Patent WO2000042044A1.

Molecular Formula	C₁₃H₁₇N₃O
Molecular Weight	231.29

α7 Nicotinic receptor agonist-1

Use of α7 Nicotinic receptor agonist-1

Names

α7 Nicotinic receptor agonist-1 Biological Activity

Chemical & Physical Properties